Skip to main content
. 2017 Jan 10;12:395–410. doi: 10.2147/IJN.S125359

Figure 7.

Figure 7

In vivo therapy of B16-F1 melanoma-bearing mice with 111In-NOTA–MNT-MSH (♦), using (A) 2.6, (B) 5.2, and (C) 10.4 MBq/mice, 111In with the same activity (▲), NOTA–MNT-MSH with the same concentration (◊), or saline (■).

Note: *P<0.05 compared to control groups, according to the one-way ANOVA test.

Abbreviations: ANOVA, analysis of variance; MNT, modular nanotransporter; MSH, α-melanocyte-stimulation hormone.